Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.50 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.50 |
| ▸ | TNF | P01375 | 2/20 | 0.50 |
| ▸ | NOD2 | Q9HC29 | 2/20 | 0.50 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5465812 | 0.86 | POLB (0.58) | CXCR4POLBTLR8HTTCYP1A2 | |
| SCHEMBL8562225 | 0.82 | POLB (0.69) | CXCR4POLBTLR8HTTCYP1A2 | |
| SCHEMBL11715808 | 0.82 | CXCR4 (0.72) | CXCR4POLBTLR8HTTCYP1A2 | |
| SCHEMBL17749602 | 0.81 | POLB (0.72) | CXCR4POLBTLR8HTTCYP1A2 | |
| Bromide SCHEMBL11712562 | 0.80 | CXCR4 (0.70) | CXCR4POLBTLR8HTTCYP1A2 | |
| SCHEMBL5127626 | 0.80 | PRMT5 (0.49) | CXCR4POLBTLR8HTTCYP1A2 | |
| SCHEMBL6199065 | 0.79 | CXCR4 (0.85) | CXCR4POLBTLR8HTTCYP1A2 | |
| SCHEMBL6930946 | 0.79 | POLB (0.69) | CXCR4POLBTLR8HTTCYP1A2 | |
| SCHEMBL5454917 | 0.78 | TLR8 (0.43) | CXCR4POLBTLR8HTTCYP1A2 | |
| Hydrochloric Acid SCHEMBL6934113 | 0.78 | POLB (0.67) | CXCR4POLBTLR8HTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070232673-A1 | 2-Imino-benzimidazoles | ABBOTT LABORATORIES | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232673-A1 | 2-Imino-benzimidazoles | CYP2C19, UGT2B7, UGT2B17 | CXCR4 3445/4885POLB 2088/4885TLR8 3837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.